IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER
Maintenance Therapy
Fudan Universitymonoclonal_antibodyPhase 2Active
CCC
53/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 38/ 100
- Competitive Position
- 81/ 100
Competitive context
8 Active assets in the Maintenance Therapy cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
S-1 The First Affiliated Hospital with Nanjing Medical University | Phase 4 | B |
Gilteritinib The First Affiliated Hospital of Soochow University | Phase 3 | B |
Sorafenib The First Affiliated Hospital of Soochow University | Phase 3 | B |
Inno-206 Fudan University | Phase 2 | CCC |
Cyclophosphamide Fudan University | Phase 2 | CCC |
PREDNISONE TABLETS Fudan University | Phase 2 | CCC |
VINCRISTINE SULFATE Fudan University | Phase 2 | CCC |
Zanubrutinib Fudan University | Phase 2 | CCC |
Same molecule, other indications
IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →